VR Stimulation of Exercise Response in Sedentary Humans

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-40
SponsorWayne State University

About this trial

Prolonged sedentary conditions contribute to declining health across human populations and cause significant secondary health consequences for many patients whose illnesses or injuries prevent them from exercising. The investigators have demonstrated that in a small animal fruit fly model, genetic stimulation of neurons that promote adrenergic signaling is sufficient to mimic the benefits of exercise training even in sedentary animals. The investigator's pilot work in humans has confirmed that humans respond to Virtual Reality (VR) stimuli that mimic exercise by increasing heart rate and altering heart rate variability in a way consistent with increased adrenergic activity.

In this study, the investigators will directly test for the first time whether repeated, controlled exposure to VR stimuli that induce adrenergic activity in sedentary humans can produce adaptive changes to protein expression and endurance performance like those produced by actual exercise in pre-diabetic participants with/without hypertension.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Equal numbers male and female (32 each)

Blood glucose HbA1C: 5.7-6.4% or 100-125 mg/dL

BP: systolic<120 and diastolic<80 mmHg, systolic 120-129 mmHg and diastolic <80 mmHg, or systolic >130 mmHg and diastolic >80 mmHg

Disqualifiers

BMI>35kg/m2

Currently involved in an exercise program or similar activity

Taking medications that could affect results, including beta-blockers or SSRIs

Demonstrate any form of discomfort with the VR experience through self-reported feelings of anxiety or nausea

Trial design

Design model

Parallel

Treatments tested in this trial

  • 20 minutes cycling exercise

    Behavioral

    20 minutes cycling exercise

  • Virtual Reality

    Behavioral

    20 minutes virtual cycling

Treatment groups

48 Participants
are divided into 3 treatment groups
Group A: EX-20 minutes sub max cycling exerciseActive comparator 1 intervention
Group B: VR-virtual reality exerciseExperimental treatment 1 intervention
Group C: VR+: 20 minutes sub max cycling exercise + virtual realityActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Blood Glucose, HbA1C

Pre-diabetic patients (Blood glucose 100-125 mg/dL, AbA1C 5.7-6.4%) may see improvement in values post-intervention

Time frame
10 weeks

Secondary outcomes

1

10 minute walk time

distance walked in 10 minutes is recorded pre- and post- intervention and may improve

Time frame
10 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Wayne State University

Lead sponsor

National Institute on Aging (NIA)

Collaborator